129 related articles for article (PubMed ID: 32766933)
1. Successful treatment of EBV-related lymphoproliferative disease after heart transplantation with autologous hematopoietic stem cell transplantation despite transient heart failure associated with engraftment syndrome.
Yasunaga M; Yasuda Y; Honda A; Maki H; Toyama K; Masamoto Y; Bujo C; Amiya E; Hatano M; Ono M; Komuro I; Kurokawa M
Ann Hematol; 2021 Apr; 100(4):1097-1100. PubMed ID: 32766933
[No Abstract] [Full Text] [Related]
2. Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.
Kuriyama T; Kawano N; Yamashita K; Ueda A
J Clin Exp Hematop; 2014; 54(2):149-53. PubMed ID: 25318948
[TBL] [Abstract][Full Text] [Related]
3. Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation.
Bunnapradist S; Vo A; Toyoda M; Alsabeh R; Lockhart C; Puliyanda D; Jordan SC
Transplantation; 2002 Dec; 74(11):1648-51. PubMed ID: 12490805
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia.
Yamaguchi J; Fujino T; Isa R; Nishiyama D; Kuwahara-Ota S; Kawaji Y; Tsukamoto T; Chinen Y; Shimura Y; Kobayashi T; Horiike S; Kohno K; Nakamura S; Kuroda J
Haematologica; 2019 Aug; 104(8):e376-e379. PubMed ID: 30975907
[No Abstract] [Full Text] [Related]
5. Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Li Z; Wang Y; Wang J; Zhang J; Wang Z
Leuk Lymphoma; 2018 Jan; 59(1):77-84. PubMed ID: 28573910
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease.
Yufu Y; Kimura M; Kawano R; Noguchi Y; Takatsuki H; Uike N; Ohshima K
Bone Marrow Transplant; 2000 Dec; 26(12):1339-41. PubMed ID: 11223975
[TBL] [Abstract][Full Text] [Related]
7. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
8. Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation.
Kim BK; Kang HJ; Hong KT; An HY; Choi JY; Lee JS; Park SS; Shin HY
Transpl Infect Dis; 2019 Dec; 21(6):e13182. PubMed ID: 31556214
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer.
Moriya K; Kikuti YY; Carreras J; Kondo Y; Shiraiwa S; Nakamura N
J Clin Exp Hematop; 2020; 60(1):11-16. PubMed ID: 32224560
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.
Liu QF; Fan ZP; Luo XD; Sun J; Zhang Y; Ding YQ
Transpl Infect Dis; 2010 Aug; 12(4):284-91. PubMed ID: 20345506
[TBL] [Abstract][Full Text] [Related]
11. Polymyositis following autologous haematopoietic stem cell transplantation.
Hedermann G; Marquart HV; Vissing J
Scand J Rheumatol; 2016 Oct; 45(5):429-31. PubMed ID: 27050436
[No Abstract] [Full Text] [Related]
12. Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
Saini NY; Patel RD; Varma A; Bashir Q; Delgado R; Rondon G; Popat U; Hosing C; Nieto Y; Kebriaei P; Weber DM; Thomas SK; Lee HC; Manasanch EE; Orlowski RZ; Champlin RE; Qazilbash MH; Patel KK
Am J Hematol; 2019 Mar; 94(3):E72-E74. PubMed ID: 30548467
[No Abstract] [Full Text] [Related]
13. Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation.
Nozzoli C; Bartolozzi B; Guidi S; Orsi A; Vannucchi AM; Leoni F; Bosi A
Leuk Lymphoma; 2006 Jan; 47(1):167-9. PubMed ID: 16321845
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
Yagi T; Ishikawa J; Aono N; Yamashita Y; Kusakabe S; Yoshinami T; Akazawa Y; Sakai D; Yamamoto S; Hamanaka Y; Masaie H; Sugimoto N; Yoshida H; Tomita Y; Imamura F
Int J Hematol; 2012 Feb; 95(2):214-6. PubMed ID: 22170229
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
[TBL] [Abstract][Full Text] [Related]
16. Fatal EBV-related post-transplant lymphoproliferative disorder (LPD) after matched related donor nonmyeloablative peripheral blood progenitor cell transplant.
Zamkoff KW; Bergman S; Beaty MW; Buss DH; Pettenati MJ; Hurd DD
Bone Marrow Transplant; 2003 Feb; 31(3):219-22. PubMed ID: 12621485
[TBL] [Abstract][Full Text] [Related]
17. EBV and posttransplantation lymphoproliferative disease: what to do?
Zimmermann H; Trappe RU
Hematology Am Soc Hematol Educ Program; 2013; 2013():95-102. PubMed ID: 24319169
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.
Meyer SC; Medinger M; Halter JP; Baldomero H; Hirsch HH; Tzankov A; Dirnhofer S; Passweg JR; Tichelli A
Hematology; 2014 Jul; 19(5):280-5. PubMed ID: 24074746
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation.
Liu L; Zhang X; Feng S
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1341-1349. PubMed ID: 29530767
[TBL] [Abstract][Full Text] [Related]
20. The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis.
Bosman G; Langemeijer SM; Hebeda KM; Raemaekers JM; Pickkers P; van der Velden WJ
Neth J Med; 2009 Sep; 67(8):364-5. PubMed ID: 19767670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
